News | April 26, 2021
Govt. approves 25 manufacturing sites for Remdesivir production
The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month
The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
The country has constantly worked with the spirit of public-private partnership
Essential medicines were made available to more than 150 countries around the world during the pandemic
Lonza's Ibex Design end-to-end offering will cover the development stages of IMT-009 from development candidates through early clinical studies
Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum
The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions
The government has taken all the effective measures to make healthcare affordable
India produces 60% of the world’s vaccine
Subscribe To Our Newsletter & Stay Updated
